Abstract:Cardiovascular disease stands as the leading cause of death globally, claiming approximately 19 million lives in 2020. On the contrary, the development of cardiovascular drugs is experiencing a decline, largely due to the bottleneck in understanding the pathophysiology of various heart diseases and assessing the effects of drugs on healthy human hearts. The development of induced pluripotent stem cell (iPSC) technology and the availability of cardiac cell types in vitro, has resulted in a surge in efforts to fabricate human cardiac models for disease modelling and drug discovery applications. Although numerous attempts evidence successful fabrication of 3 dimensional (3D) engineered heart tissues, the innate immune cell population of the myocardium ;particularly cardiac macrophages, was until recently, overlooked. With increasing appreciation of the interactions between cardiomyocytes and macrophages in the myocardium, in this work, isogenic populations of cardiac resident-like macrophages and cardiomyocytes were generated using iPSCs, to understand the interactions between the two cell types in both 2D and 3D settings, and subjected to electric stimulation. After characterizing iPSC-derived macrophages (iMacs) and iPSC-derived cardiomyocytes (iCMs) in depth, the conditioning of iMacs to align to a cardiac resident macrophage-like phenotype in the presence of iCMs in 2D culture was explored. In coculture with iCMs, iMacs upregulated known genes expressed by cardiac resident macrophages. Additionally, in co-culture with iMacs, iCMs displayed an elongated morphology, improved calcium function and an increase in known maturation genes such as the ratio between MYH7 and MYH6 as well as SERCA2. In a 2D setting, iMacs showed the ability to electrically couple with iCMs and facilitate synchronous beating in iCM cultures. The 2D characterisation was translated into an engineered cardiac tissue model, wherein, improvement in tissue characteristics in the presence of iMacs was demonstrated in terms of increased cell alignment, enhanced cardiomyocyte elongation, physiologically relevant beat rates and improved tissue compaction. Taken together, these findings may open new avenues to use iMacs in engineered cardiac tissue models, not only as an innate immune cell source, but also as a support cell type to improve cardiomyocyte function and maturation.

Cardiac Microtissues: Maladaptive Contractility of 3D Human Cardiac Microtissues to Mechanical Nonuniformity (adv. Healthcare Mater. 8/2020)

4D Printed Cardiac Construct with Aligned Myofibers and Adjustable Curvature for Myocardial Regeneration

Matrix Architecture and Mechanics Regulate Myofibril Organization, Costamere Assembly, and Contractility in Engineered Myocardial Microtissues

Micro‐Engineered Heart Tissues on‐Chip with Heterotypic Cell Composition Display Self‐Organization and Improved Cardiac Function

A Data-Driven Computational Model for Engineered Cardiac Microtissues

Digital Light Processing 3D Printing enables High Throughput Fabrication of Human Engineered Heart Tissues for Disease Modeling

Probing Subcellular Nanostructure of Engineered Human Cardiomyocytes in 3D Tissue

GelMA Micropattern Enhances Cardiomyocyte Organization, Maturation, and Contraction Via Contact Guidance.

Traction Force Microscopy of Engineered Cardiac Tissues

Engineered human cardiac tissues for modeling heart diseases

Synergistic generation of cardiac resident-like macrophages and cardiomyocyte maturation in tissue engineered platforms

Rapid 3D Bioprinting of in Vitro Cardiac Tissue Models Using Human Embryonic Stem Cell-Derived Cardiomyocytes.

Strategies for Constructing Pluripotent Stem Cell- and Progenitor Cell-Derived Three-Dimensional Cardiac Micro-Tissues.

Structural maturation of myofilaments in engineered 3D cardiac microtissues characterized using small angle X-ray scattering

Biomimetic Cardiac Microsystems for Pathophysiological Studies and Drug Screens

Engineering Three-Dimensional Cardiac Microtissues for Potential Drug Screening Applications.

Versatile human cardiac tissues engineered with perfusable heart extracellular microenvironment for biomedical applications

Nonclinical evaluation of chronic cardiac contractility modulation on 3D human engineered cardiac tissues

Engineering Cardiac Tissue for Advanced Heart‐on‐a‐chip Platforms

Multicellular Interactions in 3D Engineered Myocardial Tissue